Westside Investment Management’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.4K | Sell |
21,375
-67,825
| -76% | -$157K | 0.01% | 460 |
|
|
2025
Q1 | $697K | Sell |
89,200
-775
| -0.9% | -$6.05K | 0.15% | 133 |
|
|
2024
Q4 | $420K | Buy |
89,975
+18,660
| +26% | +$87.1K | 0.09% | 162 |
|
|
2024
Q3 | $384K | Buy |
71,315
+25,975
| +57% | +$140K | 0.08% | 168 |
|
|
2024
Q2 | $400K | Buy |
45,340
+10,950
| +32% | +$96.6K | 0.09% | 158 |
|
|
2024
Q1 | $404K | Sell |
34,390
-7,475
| -18% | -$87.8K | 0.1% | 159 |
|
|
2023
Q4 | $471K | Buy |
41,865
+325
| +0.8% | +$3.66K | 0.12% | 146 |
|
|
2023
Q3 | $281K | Sell |
41,540
-700
| -2% | -$4.74K | 0.08% | 178 |
|
|
2023
Q2 | $384K | Buy |
42,240
+5,135
| +14% | +$46.6K | 0.11% | 160 |
|
|
2023
Q1 | $240K | Buy |
37,105
+6,715
| +22% | +$43.4K | 0.07% | 190 |
|
|
2022
Q4 | $192 | Buy |
30,390
+150
| +0.5% | +$1 | ﹤0.01% | 322 |
|
|
2022
Q3 | $187 | Buy |
30,240
+100
| +0.3% | +$1 | ﹤0.01% | 321 |
|
|
2022
Q2 | $266 | Buy |
30,140
+3,750
| +14% | +$33 | ﹤0.01% | 310 |
|
|
2022
Q1 | $222 | Buy |
26,390
+18,590
| +238% | +$156 | ﹤0.01% | 319 |
|
|
2021
Q4 | $79 | Buy |
+7,800
| New | +$79 | ﹤0.01% | 364 |
|